Edge Therapeutics, Inc. 4
4 · Edge Therapeutics, Inc. · Filed Mar 2, 2017
Insider Transaction Report
Form 4
Wyant Alyssa
SVP Regulatory Affairs
Transactions
- Award
Stock Option (right To Purchase)
2017-03-01$9.81/sh+80,000$784,800→ 80,000 totalExercise: $9.81Exp: 2027-02-28→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]This option, representing a right to purchase a total of 80,000 shares of Common Stock, will become exercisable on February 21, 2018, with a 25% vesting on that date and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date.